InsidersTradesSigma
Follow the ThermoGenesis Holdings, Inc. stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, ThermoGenesis Holdings, Inc. has recorded 5 public disclosures. Market capitalisation: €2k. The latest transaction was filed on 9 July 2024 (C). Among the most active insiders: Xu Xiaochun. Every trade is openly available.
5
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
1 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 July 2024
Declarations5 total
7,894,737 shares@ €0.354933.7% of flowCommon StockSEC:0001437749-24-022423:0
4,113,158 shares@ €0.349217.3% of flowCommon StockSEC:0001437749-24-008468:0
600,000 shares@ €0.93986.8% of flowCommon StockSEC:0000897069-23-001629:0
654,206 shares@ €1.0138.0% of flowCommon StockSEC:0001437749-23-027433:0
10,552,234 shares@ €0.2702100.0% of flowCommon StockSEC:0001437749-22-016295:0
5 of 5 declarations
About ThermoGenesis Holdings, Inc.
ThermoGenesis Holdings, Inc. is a company focused on developing cell therapy solutions and biological products. It concentrates on applications in regenerative medicine and transplantation.